These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 25880946)

  • 21. Accelerated versus classical hepatitis B virus vaccination programs in healthcare workers accelerated vs. classical HBV vaccination.
    Tarhan MO; Aker AI; Sipahi OR; Kardes G; Biberoglu K
    Med Sci Monit; 2006 Nov; 12(11):CR467-70. PubMed ID: 17072271
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High rates of serological response to a modified hepatitis B vaccination schedule in HIV-infected adults subjects.
    Potsch DV; Oliveira ML; Ginuíno C; Miguel JC; Oliveira SA; Silva EF; Moreira RB; Cruz GV; Oliveira AL; Camacho LA; Barroso PF
    Vaccine; 2010 Feb; 28(6):1447-50. PubMed ID: 19995540
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of accelerated hepatitis B vaccination program in patients being actively treated for hematologic malignancies.
    Pullukcu H; Ertem E; Karaca Y; Yamazhan T; Sertoz RY; Altuglu I
    Int J Infect Dis; 2008 Mar; 12(2):166-70. PubMed ID: 17720599
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of high dose and short interval HBV vaccination in individuals with chronic hepatitis C.
    Idilman R; De MN; Colantoni A; Nadir A; Van Thiel DH
    Am J Gastroenterol; 2002 Feb; 97(2):435-9. PubMed ID: 11866284
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decline in hepatitis B infection observed after 11 years of regional vaccination among Danish drug users.
    Mössner BK; Skamling M; Jørgensen TR; Georgsen J; Pedersen C; Christensen PB
    J Med Virol; 2010 Oct; 82(10):1635-9. PubMed ID: 20827758
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impaired antibody response rates after high dose short interval hepatitis B virus vaccination of immunosuppressed individuals.
    Idilman R; Colantoni A; De Maria N; Ustun C; Sam R; Ing TS; Akan H; Koc H; Van Thiel DH
    Hepatogastroenterology; 2003; 50(49):217-21. PubMed ID: 12630026
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Eight years of hepatitis B vaccination in Colombia with a recombinant vaccine: factors influencing hepatitis B virus infection and effectiveness.
    de la Hoz F; Perez L; de Neira M; Hall AJ
    Int J Infect Dis; 2008 Mar; 12(2):183-9. PubMed ID: 17913535
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibody titration and immune response of Iranian beta-thalassemic patients to hepatitis B virus vaccine (booster effect).
    Azarkeivan A; Karimi G; Shaiegan M; Maghsudlu M; Tabbaroki A
    Pediatr Hematol Oncol; 2009 Jun; 26(4):195-201. PubMed ID: 19437322
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term response rates of successful hepatitis B vaccination in HIV-infected patients.
    Lopes VB; Hassing RJ; de Vries-Sluijs TE; El Barzouhi A; Hansen BE; Schutten M; de Man RA; van der Ende ME
    Vaccine; 2013 Feb; 31(7):1040-4. PubMed ID: 23273969
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseases.
    Wörns MA; Teufel A; Kanzler S; Shrestha A; Victor A; Otto G; Lohse AW; Galle PR; Höhler T
    Am J Gastroenterol; 2008 Jan; 103(1):138-46. PubMed ID: 17970833
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Implementation of a hepatitis A/B vaccination program using an accelerated schedule among high-risk inmates, Los Angeles County Jail, 2007-2010.
    Costumbrado J; Stirland A; Cox G; El-Amin AN; Miranda A; Carter A; Malek M
    Vaccine; 2012 Nov; 30(48):6878-82. PubMed ID: 22989688
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessing the immunological response to hepatitis B vaccination in HIV-infected patients in clinical practice.
    Mena G; Llupià A; García-Basteiro AL; Díez C; León A; García F; Bayas JM
    Vaccine; 2012 May; 30(24):3703-9. PubMed ID: 22446635
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis B vaccination schedules in genitourinary medicine clinics.
    Asboe D; Rice P; de Ruiter A; Bingham JS
    Genitourin Med; 1996 Jun; 72(3):210-2. PubMed ID: 8707326
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness and impact of hepatitis B virus vaccination of children with at least one parent born in a hepatitis B virus endemic country: an early assessment.
    Hontelez JA; Hahné S; Koedijk FH; de Melker HE
    J Epidemiol Community Health; 2010 Oct; 64(10):890-4. PubMed ID: 19822551
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Schedules for hepatitis B vaccination of risk groups: balancing immunogenicity and compliance.
    Van Herck K; Leuridan E; Van Damme P
    Sex Transm Infect; 2007 Oct; 83(6):426-32. PubMed ID: 17911142
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Control of hepatitis B in French Polynesia with a program of systematic vaccination of newborns with the Genhevac B vaccine].
    Moulia-Pelat JP; Spiegel A; Excler JL; Martin P; Roux JF; Boutin JP; Blondeau C; Saliou P
    Sante; 1996; 6(1):11-5. PubMed ID: 8612008
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of hepatitis B and A virus markers and vaccination indication in cirrhotic patients evaluated for liver transplantation in Spain.
    Gutiérrez Domingo I; Pascasio Acevedo JM; Alcalde Vargas A; Ramos Cuadra A; Ferrer Ríos MT; Sousa Martín JM; Sayago Mota M; Giráldez Gallego A; Suárez Artacho G
    Transplant Proc; 2012; 44(6):1502-4. PubMed ID: 22841196
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of hepatitis B vaccine boosters among neonatally vaccinated university freshmen in Taiwan.
    Su FH; Chu FY; Bai CH; Lin YS; Hsueh YM; Sung FC; Yeh CC
    J Hepatol; 2013 Apr; 58(4):684-9. PubMed ID: 23207141
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study.
    Zanetti AR; Mariano A; Romanò L; D'Amelio R; Chironna M; Coppola RC; Cuccia M; Mangione R; Marrone F; Negrone FS; Parlato A; Zamparo E; Zotti C; Stroffolini T; Mele A;
    Lancet; 2005 Oct 15-21; 366(9494):1379-84. PubMed ID: 16226616
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis B vaccination in prison with a 3-week schedule is more efficient than the standard 6-month schedule.
    Christensen PB; Fisker N; Krarup HB; Liebert E; Jaroslavtsev N; Christensen K; Georgsen J
    Vaccine; 2004 Sep; 22(29-30):3897-901. PubMed ID: 15364437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.